QR-koda

iNOS is a key mediator of anti-PD-1 melanoma therapy response

BackgroundInducible nitric oxide synthase (iNOS) and its product nitric oxide (NO) were historically linked to poor melanoma outcomes, yet recent evidence shows NO supports anti-tumor immunity. This study examines how iNOS shapes anti–PD-1 efficacy, particularly through interferon signaling.MethodsB...

Olles dieđut

Furkejuvvon:
Váldodahkkit: Quang Tam Nguyen, Youngchul Kim, Thi Hong Nga Le, Saurabh Garg, Vishanna Balkaran, Trisha Bhathivi, Alejandra Chamizo, Christopher W. Dukes, Kimberly Ward, Andrew S. Brohl, Lilit Karapetyan, Nikhil I. Khushalani, Zeynep Eroglu, Ahmad A. Tarhini, James J. Mulé, Joseph Markowitz
Materiálatiipa: Artigo
Giella:Inglês
Almmustuhtton: Frontiers Media S.A. 2026-06-01
Ráidu:Frontiers in Immunology
Fáttát:
anti-PD-1
immunotherapy
iNOS
melanoma
nitric oxide
Liŋkkat:https://www.frontiersin.org/articles/10.3389/fimmu.2026.1837275/full
Fáddágilkorat: Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!

Geahča maid